Eligibility Esophageal Squamous Cell Carcinoma NCT01258192

Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01258192

Eligibility Esophageal Squamous Cell Carcinoma NCT01258192

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Squamous cell carcinoma of esophagus Preoperative TNM clinical staging
Item
histologic diagnosis of squamous cell carcinoma of esophagus. preoperative stage ⅱ-ⅲ
boolean
C0279626 (UMLS CUI [1,1])
C0445204 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
Endoscopic Ultrasound | CT of chest and abdomen | Esophagram
Item
by endoscopic ultrasound, ct of the chest and abdomen,and esophagogram.
boolean
C0376443 (UMLS CUI [1])
C1630402 (UMLS CUI [2])
C1318509 (UMLS CUI [3])
Age
Item
age ranges from 18 to 70 years.
boolean
C0001779 (UMLS CUI [1])
Cancer treatment Absent
Item
patients must not have received any prior anticancer therapy.
boolean
C0920425 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Performance status
Item
performance status of 0 to 1
boolean
C1518965 (UMLS CUI [1])
Life Expectancy
Item
estimated life expectancy of at least 6 months.
boolean
C0023671 (UMLS CUI [1])
Neoplasm Measurable
Item
tumor can be measured according to recist criteria
boolean
C0027651 (UMLS CUI [1,1])
C1513040 (UMLS CUI [1,2])
Informed Consent
Item
signed informed consent document on file.
boolean
C0021430 (UMLS CUI [1])
Childbearing Potential Serum pregnancy test negative
Item
females with childbearing potential must have a negative serum pregnancy
boolean
C3831118 (UMLS CUI [1,1])
C0430061 (UMLS CUI [1,2])
Organ function
Item
adequate organ function including the following:
boolean
C0678852 (UMLS CUI [1])
Bone Marrow function | Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement | Liver function | Serum total bilirubin measurement | Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Renal function | Estimation of creatinine clearance by Cockcroft-Gault formula
Item
bone marrow: absolute neutrophil count (anc) greater than or equal 1.5×109/l platelets greater than or equal 80×109/l haemoglobin greater than or equal 80g/l hepatic: total bilirubin less than or equal to 1.5 times upper limit of normal (uln), alanine transaminase (alt) and aspartate transaminase (ast) less than or equal to 2.5 times uln renal: calculated creatinine clearance rate≥60ml/min. test within 7 days prior to study enrollment.
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0948762 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0518015 (UMLS CUI [4])
C0232741 (UMLS CUI [5])
C1278039 (UMLS CUI [6])
C0201836 (UMLS CUI [7])
C0201899 (UMLS CUI [8])
C0232804 (UMLS CUI [9])
C2711451 (UMLS CUI [10])
Item Group
C0680251 (UMLS CUI)
Carcinoma of upper third of esophagus
Item
carcinoma at the upper part of esophagus
boolean
C0345779 (UMLS CUI [1])
Adenocarcinoma Of Esophagus
Item
histologic diagnosis of adenocarcinoma of esophagus.
boolean
C0279628 (UMLS CUI [1])
Prior Therapy Esophageal carcinoma
Item
prior treatment for esophageal cancer.
boolean
C1514463 (UMLS CUI [1,1])
C0152018 (UMLS CUI [1,2])
Communicable Disease
Item
active infection.
boolean
C0009450 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant or breast feeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Nervous system disorder | Mental disorders | Seizures | Dementia
Item
history of significant neurological or mental disorder, including seizures or dementia.
boolean
C0027765 (UMLS CUI [1])
C0004936 (UMLS CUI [2])
C0036572 (UMLS CUI [3])
C0497327 (UMLS CUI [4])
invasive cancer | Exception Carcinoma in Situ
Item
prior invasive malignancy in 5 years (except for carcinoma in situ).
boolean
C0677898 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007099 (UMLS CUI [2,2])